COVID-19 IgM/IgG Rapid Test
Coronavirus Disease 2019, or COVID-19, is a novel respiratory disease that has characterized as a pandemic by the World Health Organization.
On March 16, 2020, the FDA updated its Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency to included guidance for serology tests that identify antibodies (e.g., IgM, IgG) to SARS-CoV-2 from clinical specimens; allowing healthcare entities to perform testing at the point-of-care.
Rapid screening of individuals with this virus is vital in addressing this escalating public health issue. Recent studies suggest that a high percentage of patients show no clinical symptoms of the SARS-CoV-2 virus, thus screening patients is vitally important.
Features & Benefits
BitCare Rapid IgM-IgG Combined Antibody Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro.
- Works with whole blood, serum, & plasma
- Tests for both IgM and IgG antibodies
- Validated using PCR
- 10-15 minutes per test
- Intuitive visual interpretation
- No special equipment needed
How It Works
Add blood sample
to sample well
Place 2-3 drops of
buffer in sample well
Read results after
The COVID-19 IgM/IgG Rapid Test is ideally suited for hospitals, clinics, care facilities, laboratories, and mobile clinics. The test can potentially be effectively deployed in schools, airports, seaports, businesses, community centers, senior living, nursing homes, care facilities, etc., giving it the potential to become a compelling force in the fight against this pandemic.
General Population Screening
- Allows rapid examination and diagnosis near the point of care
Hospitals, Physician Offices, Laboratories
- Can screen carriers who are asymptomatic
- Can determine if the patient recently affected by the virus, even if the virus is no longer present
NOTE: Updated USFDA guidance issued on March 16, 2020, allows the distribution of this product for diagnostic use in laboratories or by healthcare workers at the point-of-care. The updated policy can be viewed by clicking here. Please see FAQ’s below for more detailed information.
COVID-19 IgM/IgG Rapid Test
COVID-19 Testing: PCR Versus Serology Testing, Explained
There are two types of tests available for COVID-19 that can detect whether a person had it in the past (serology testing, which tests for antibodies against SARS-CoV-2, the virus that causes COVID-19), or whether they have it in the present (polymerase chain reaction (PCR) testing, which tests for active infection). This document is designed to explain the differences between PCR and serology testing, and when one test might be used over another.
Subscribe to our newsletter for updates and special offers
Disclaimer: All information provided on site and in reports produced is intended to support nutritional advice to optimise your diet. We do not claim or attempt to claim to diagnose medical conditions, or cure or treat medical conditions.
Blood (ELISA) tests define an intolerance/sensitivity as a specific IgG4 reaction and an allergy as a specific IgE reaction (IgE-Mediated).
Hair tests (Bioresonance Therapy) is categorised as Complementary and Alternative Medicines (CAMs) covering therapies that fall outside mainstream medicine. Conventional medicine does not currently recognise Bioresonance as it has not been subject to significant scientific research. Bioresonance reports and related information do not make a medical diagnosis nor is it intended to be a substitute for professional medical advice, diagnosis, or treatment.
Always seek the advice of your doctor or other qualified health provider if you have a medical condition and/or medical symptoms. Never disregard professional medical advice or delay in seeking it. All probable or possible information provided in reports or on this website need to be discussed and confirmed with a nutritional therapist or qualified medical practitioner.